Soluble intercellular adhesion molecule-1 and E-selectin in patients with asthma exacerbation Source: Annual Congress 2009 - Inflammation and airways Year: 2009
Serum level of soluble vascular cell adhesion molecule-1 (sVCAM-1) in bronchial asthma in children Source: Eur Respir J 2003; 22: Suppl. 45, 399s Year: 2003
Soluble form of intercellular adhesion molecule-1 as a serum marker of inflammation activity in cryptogenic fibrosing alveolitis Source: Eur Respir J 2004; 24: Suppl. 48, 356s Year: 2004
Soluble intercellular adhesion molecule 1 (ICAM-1) antigen in sera of asthmatic children Source: Eur Respir J 2002; 20: Suppl. 38, 140s Year: 2002
Increased levels of soluble intercellular adhesion molecule 1 in active smokers Source: Annual Congress 2012 - Inflammatory mechanisms in COPD Year: 2012
Influence of obstructive sleep apnea on soluble intercellular adhesion molecule-1 and vascular endothelial growth factor Source: Eur Respir J 2004; 24: Suppl. 48, 332s Year: 2004
Effects of perfluorocarbon on lipopolysaccharide-induced intercellular adhesion molecule-1 expression in cultured pulmonary microvascular endothelial cells Source: Eur Respir J 2007; 30: Suppl. 51, 295s Year: 2007
Expression of LFA-1 and L-selectin on PMN and level of soluble sE-selectin and sL-selectin in patients with small cell lung cancer (SCLC) Source: Eur Respir J 2002; 20: Suppl. 38, 231s Year: 2002
Vascular cell adhesion molecule I (VCAM-1) expression in pulmonary leptospirosis Source: Eur Respir J 2007; 30: Suppl. 51, 722s Year: 2007
CD34, VCAM-1, E-Selectin and ICAM-1 expression in major types of idiopathic interstitial pneumonia Source: Eur Respir J 2005; 26: Suppl. 49, 267s Year: 2005
A soluble adhesion molecule ‘E-selectin‘; an activation marker and prognostic indicator in sarcoidosis? Source: Eur Respir J 2005; 26: Suppl. 49, 685s Year: 2005
Overnight change of circulating intercellular adhesion molecule-1 levels in children with sleep disordered breathing Source: Eur Respir J 2006; 28: Suppl. 50, 533s Year: 2006
Expression of the intercellular adhesion molecule ICAM-1 on alveolar macrophages in healthy subjects and non-small cell lung cancer patients Source: Eur Respir J 2002; 20: Suppl. 38, 276s Year: 2002
Decrease of soluble adhesion molecules levels and bacterial mixt-infection in patients with COPD Source: Annual Congress 2011 - COPD: human studies Year: 2011
Ang-1/BMPR2 signaling and the expressions of MCP-1 and ICAM in over circulation-induced experimental pulmonary hypertension Source: Eur Respir J 2004; 24: Suppl. 48, 533s Year: 2004
Soluble intercellular adhesion molecule - 1, interleukin - 8 and C5a complement component as markers of inflammation in cryptogenic fibrosing alveolitis Source: Eur Respir J 2002; 20: Suppl. 38, 312s Year: 2002
Cilomilast but not salmeterol blocks β2 -integrin adhesion of human polymorphonuclear leukocytes to soluble ICAM-1 Source: Eur Respir J 2005; 26: Suppl. 49, 222s Year: 2005
Platelet activating factor increases β2 -integrin mediated eosinophil adhesion to ICAM-1 through focal clustering of CD11b Source: Annual Congress 2004 - Genetics and molecular mechanisms of COPD and asthma Year: 2004
Role of ICAM-2 in neutrophil transepithelial migration in the lung Source: Annual Congress 2012 - Molecular biology of pro- and anti-inflammatory responses in the lung Year: 2012
Fluvastatin and lovastatin inhibit human eosinophil, but not neutrophil, adhesion to ICAM-1 under flow conditions Source: Annual Congress 2008 - Novel therapeutic approaches and immunological mechanisms in airway cell pathobiology Year: 2008